-
Awards for AI-based drug R&D continue for second year
pharmaphorum
December 10, 2018
UK health technology firm BenevolentAI and the Association of Medical Research Charities are continuing an award encouraging use of artificial intelligence (AI) to develop new therapies for a second year.
-
UCB to invest £1bn in the UK Life Sciences Sector Deal
pharmaceutical-technology
December 06, 2018
Belgian biopharmaceutical company UCB has agreed to invest approximately £1bn ($1.27bn) as part of a collaboration between the UK government and life sciences industry intended to support healthcare innovation in the country......
-
Government challenges medical devices firms to improve NHS
pharmaphorum
November 26, 2018
The UK’s government is urging businesses to apply for a share of up to £1.5 million to support real-world testing of medical devices and digital technology that could make the NHS more efficient, and enable earlier diagnosis of cancer.
-
Jobs and Elon Musk in the Life Sciences Community? Stephen Hoge will Disrupt the Entire Monoclonal Antibody Industry with mRNA Therapy
Chen Bin
September 21, 2018
Stephen Hoge will Disrupt the Entire Monoclonal Antibody Industry with mRNA Therapy
-
Neuron Biohub envisions setting global standards in life sciences
biospectrumasia
August 14, 2018
Supporting healthcare and improving life has been a key driving passion of the company.
-
OncoCyte appoints Albert P. Parker as COO
biospectrumasia
August 13, 2018
Mr. Parker has extensive experience working with companies to maximize commercial and strategic opportunities and has played a central role on numerous business development transactions.
-
TTP completes expansion of life sciences lab facility for Desktop Biology programmes
cphi-online
August 06, 2018
Dedicated facility developed in response to increasing demand for product development projects in diagnostics, R&D and bioprocess.
-
Werfen Increases Sales by Over 13% and Reaffirms Its Global Leadership in In Vitro Diagnostics
en-cphi.cn
May 07, 2018
Werfen, a global leader in healthcare and life sciences, achieves revenues of 1,337 million euros in 2017, a 13.3% increase against 2016.
-
Werfen sales Increases over 13 per cent
biospectrumasia
April 28, 2018
Werfen has strengthened its presence in all regions, especially in China, where sales have achieved a 21% increase against 2016. Currently, Asia-Pacific accounts for 16% of total revenues.
-
UK seeks investment from health and life sciences companies worldwide
biospectrumasia
March 14, 2018
The UK is the number one destination for health and life sciences foreign direct investment in Europe.